Modeling the host response to inhalation anthrax

Journal of Theoretical Biology

Volumn 276, Issue 1, 2011, Pages 199-208

  Day, Judy ^a   Friedman, Avner ^a   Schlesinger, Larry S ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Bacillus anthracis; Mathematical modeling; Neutrophil response; Respiratory pathogens

Indexed keywords

ANTHRAX TOXIN; CIPROFLOXACIN; DOXYCYCLINE;

ANTHRAX; ANTIBIOTICS; BACTERIUM; GERMINATION; NUMERICAL MODEL; PATHOGEN; RESPIRATORY DISEASE;

ANTHRAX; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL GROWTH; BACTERIAL LOAD; BACTERIAL SPORE; CELL INTERACTION; CELL MIGRATION; COMPARTMENT MODEL; DISEASE TRANSMISSION; IMMUNE RESPONSE; MEDIASTINUM LYMPH NODE; PATHOGENESIS; PHAGOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; SPORE GERMINATION; SURVIVAL RATE; THORAX; TREATMENT DURATION;

ANTHRAX; ANTI-BACTERIAL AGENTS; BACILLUS ANTHRACIS; COMPUTER SIMULATION; GERMINATION; HOST-PATHOGEN INTERACTIONS; HUMANS; INHALATION EXPOSURE; INTRACELLULAR SPACE; MICROBIAL VIABILITY; MODELS, BIOLOGICAL; PHAGOCYTOSIS;

BACILLUS ANTHRACIS; BACTERIA (MICROORGANISMS);

EID: 79952065868     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2011.01.054     Document Type: Article

References (66)

1. Baldari C.T., Tonello F., Paccani S.R., Montecucco C. Anthrax toxins: a paradigm of bacterial immune suppression. Trends Immunol. 2006, 27:434-440.
2. Banks D.J., Barnajian M., Maldonado-Arocho F.J., Sanchez A.M., Bradley K.A. Anthrax toxin receptor 2 mediates Bacillus anthracis killing of macrophages following spore challenge. Cell Microbiol. 2005, 7:1173-1185.
3. Banks D.J., Ward S.C., Bradley K.A. New insights into the functions of anthrax toxin. Expert Rev. Mol. Med. 2006, 8:1-18.
4. Bayer Healthcare Pharmaceuticals, 2009. Cipro® I.V. package insert.
5. Brittingham K.C., Ruthel G., Panchal R.G., Fuller C.L., Ribot W.J., Hoover T.A., Young H.A., Anderson A.O., Bavari S. Dendritic cells endocytose Bacillus anthracis spores: implications for anthrax pathogenesis. J. Immunol. 2005, 174:5545-5552.
6. CDC-Centers for Disease Control and Prevention, 2010. Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. Morbidity and Mortality Weekly Report, 59(RR-6), pp. 1-36.
7. CDC-Centers for Disease Control and Prevention, 2005. Anthrax Q & A: preventive therapy. 〈〉 (updated March 25, 2005; accessed July 6, 2010). http://www.bt.cdc.gov/agent/anthrax/faq/preventive.asp.
8. Chow C.C., Clermont G., Kumar R., Lagoa C., Tawadrous Z., Gallo D., Betten B., Bartels J., Constantine G., Fink M.P., Billiar T.R., Vodovotz Y. The acute inflammatory response in diverse shock states. Shock 2005, 24:74-84.
9. Cleret A., Quesnel-Hellmann A., Vallon-Eberhard A., Verrier B., Jung S., Vidal D., Mathieu J., Tournier J.N. Lung dendritic cells rapidly mediate anthrax spore entry through the pulmonary route. J. Immunol. 2007, 178:7994-8001.
10. Clermont G., Bartels J., Kumar R., Constantine G., Vodovotz Y., Chow C. In silico design of clinical trials: a method coming of age. Crit. Care Med. 2004, 32:2061-2070.
11. Coleman M.E., Thran B., Morse S.S., Hugh-Jones M., Massulik S. Inhalation anthrax: dose response and risk analysis. Biosecur. Bioterror. 2008, 6:147-160. 10.1089/bsp.2007.0066.
12. Cote C.K., Rea K.M., Norris S.L., van Rooijen N., Welkos S.L The use of a model of in vivo macrophage depletion to study the role of macrophages during infection with Bacillus anthracis spores. Microb. Pathog. 2004, 37:169-175.
13. Cote C.K., Van Rooijen N., Welkos S.L. Roles of macrophages and neutrophils in the early host response to Bacillus anthracis spores in a mouse model of infection. Infect. Immunol. 2006, 74:469-480.
14. Cote C.K., DiMezzo T.L., Banks D.J., France B., Bradley K.A., Welkos S.L. Early interactions between fully virulent Bacillus anthracis and macrophages that influence the balance between spore clearance and development of a lethal infection. Microb. Infect. 2008, 10:613-619.
15. Day J., Friedman A., Schlesinger L.S. Modeling the immune rheostat of macrophages in the lung in response to infection. Proc. Natl. Acad. Sci. USA 2009, 106:11246-11251.
16. DeLeo F.R. Modulation of phagocyte apoptosis by bacterial pathogens. Apoptosis 2004, 9:399-413.
17. Dietrich C.F., Chichakli M., Bargon J., Wehrmann T., Wiewrodt R., Buhl R., Caspary W.F. Mediastinal lymph nodes demonstrated by mediastinal sonography: activity marker in patients with cystic fibrosis. J. Clin. Ultrasound 1999, 27:9-14.
18. Dirckx J.H. Virgil on anthrax. Am. J. Dermatophathol 1981, 3:191-195.
19. Dixon T.C., Meselson M., Guillemin J., Hanna P.C. Anthrax. N. Engl. J. Med. 1999, 341:815-826.
20. Dixon T.C., Fadl A.A., Koehler T.M., Swanson J.A., Hanna P.C. Early Bacillus anthracis-macrophage interactions: intracellular survival survival and escape. Cell Microbiol. 2000, 2:453-463.
21. During R.L., Li W., Hao B., Koenig J.M., Stephens D.S., Quinn C.P., Southwick F.S. Anthrax lethal toxin paralyzes neutrophil actin-based motility. J. Infect. Dis. 2005, 192:837-845.
22. Doxycycline-an overview. 〈〉 (accessed May 20, 2010). http://www.cbwinfo.com/Pharmaceuticals/Doxycycline.html.
23. Erwin J.L., DaSilva L.M., Bavari S., Little S.F., Friedlander A.M., Chanh T.C. Macrophage-derived cell lines do not express proinflammatory cytokines after exposure to Bacillus anthracis lethal toxin. Infect. Immun. 2001, 69:1175-1177.
24. Fennelly K.P., Davidow A.L., Miller S.L., Connell N., Ellner J.J. Airborne infection with Bacillus anthracis-from mills to mail. Emerg. Infect. Dis. 2004, 10:996-1002.
25. Fink S.L., Bergsbaken T., Cookson B.T. Anthrax lethal toxin and Salmonella elicit the common cell death pathway of caspase-1-dependent pyroptosis via distinct mechanisms. Proc. Natl. Acad. Sci. USA 2008, 105:4312-4317.
26. Friedlander A.M., Welkos S.L., Pitt M.L., Ezzell J.W., Worsham P.L., Rose K.J., Ivins B.E., Lowe J.R., Howe G.B., Mikesell P., Lawrence W.B. Postexposure prophylaxis against experimental inhalation anthrax. J. Infect. Dis. 1993, 167:1239-1243.
27. Furniss P.R., Hahn B.D. A mathematical model of an anthrax epizootic in the Kruger National Park. Appl. Math. Model. 1981, 5:130-136. 10.1016/0307-904X(81)90034-2.
28. Guarner J., Jernigan J.A., Shieh W.J., Tatti K., Flannagan L.M., Stephens D.S., Popovic T., Ashford D.A., Perkins B.A., Zaki S.R., Inhalational Anthrax Pathology Working Group Pathology and pathogenesis of bioterrorism-related inhalational anthrax. Am. J. Pathol. 2003, 163:701-709.
29. Guidi-Rontani C., Weber-Levy M., Labruyère E., Mock M. Germination of Bacillus anthracis spores within alveolar macrophages. Mol. Microbiol. 1999, 31:9-17.
30. Guidi-Rontani C. The alveolar macrophage: the Trojan horse of Bacillus anthracis. Trends Microbiol. 2002, 10:405-409.
31. Hampton M.B., Vissers M.C., Winterbourn C.C. A single assay for measuring the rates of phagocytosis and bacterial killing by neutrophils. J. Leukoc. Biol. 1994, 55:147-152.
32. Hanna P.C., Ireland J.A. Understanding Bacillus anthracis pathogenesis. Trends Microbiol. 1999, 7:180-182.
33. Hanna P. Anthrax pathogenesis and host response. Curr. Top. Microbiol. Immunol. 1998, 225:13-35.
34. Hanna P.C., Kruskal B.A., Ezekowitz R.A., Bloom B.R., Collier R.J. Role of macrophage oxidative burst in the action of anthrax lethal toxin. Mol. Med. 1994, 1:7-18.
35. Hanna P. On the role of macrophages in anthrax. Proc. Natl. Acad. Sci. 1993, 90:10198-10201.
36. Kalns J., Morris J., Eggers J., Kiel J. Delayed treatment with doxycycline has limited effect on anthrax infection in BLK57/B6 mice. Biochem. Biophys. Res. Commun. 2002, 297:506-509.
37. Kobzik L. Lung defenses. Dail and Hammar's Pulmonary Pathology: Volume I Nonneoplastic Lung Disease 2008, 49-63. Springer. 3rd edn. D.H. Dail, J.F. Tomashefski, S.P. Hammar, P.T. Cagle, C.F. Farer, A.E. Fraire (Eds.).
38. Kumar R., Chow C.C., Bartels J.D., Clermont G., Vodovotz Y. A mathematical simulation of the inflammatory response to anthrax infection. Shock 2008, 29:104-111.
39. Maldonado-Arocho F.J., Bradley K.A. Anthrax edema toxin induces maturation of dendritic cells and enhances chemotaxis towards macrophage inflammatory protein 3-beta. Infect. Immun. 2009, 77:2036-2042.
40. Marino S., Hogue I.B., Ray C.J., Kirschner D.E. A methodology for performing global uncertainty and sensitivity analysis in systems biology. J. Theor. Biol. 2008, 254:178-196.
41. Mayer G. Bacteriology. Microbiology and Immunolgy On-line 2010, University of South Carolina School of Medicine. R.C. Hunt (Ed.).
42. Mayer-Scholl A., Hurwitz R., Brinkmann V., Schmid M., Jungblut P., Weinrauch Y., Zychlinsky A. Human neutrophils kill Bacillus anthracis. PLoS Pathog. 2005, 1:e23.
43. Meselson M., Guillemin J., Hugh-Jones M., Langmuir A., Popova I., Shelokov A., Yampolskaya O. The Sverdlovsk anthrax outbreak of 1979. Science 1999, 266:1202-1208.
44. O'Brien J., Friedlander A., Dreier T., Ezzell J., Leppla S. Effects of anthrax toxin components on human neutrophils. Infect. Immun. 1985, 47:306-310.
45. Pellizzari R., Guidi-Rontani C., Vitale G., Mock M., Montecucco C. Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNgamma-induced release of NO and TNFalpha. FEBS Lett. 1999, 462:199-204.
46. Popov S.G., Popova T.G., Grene E., Klotz F., Cardwell J., Bradburne C., Jama Y., Maland M., Wells J., Nalca A., Voss T., Bailey C., Alibek K. Systemic cytokine response in murine anthrax. Cell Microbiol. 2004, 6:225-233.
47. Popov S.G., Villasmil R., Bernardi J., Grene E., Cardwell J., Wu A., Alibek D., Bailey C., Alibek K. Lethal toxin of Bacillus anthracis causes apoptosis of macrophages. Biochem. Biophys. Res. Commun. 2002, 293:349-355.
48. Popov S.G., Villasmil R., Bernardi J., Grene E., Cardwell J., Popova T., Wu A., Alibek D., Bailey C., Alibek K. Effect of Bacillus anthracis lethal toxin on human peripheral blood mononuclear cells. FEBS Lett. 2002, 527:211-215.
49. Popov S.G. New candidate anthrax pathogenic factors. National Institute of Allergy and Infectious Diseases, NIH Volume I Frontiers in Research 2008, Humana Press, Totowa, New Jersey, pp. 25-35. 10.1007/978-1-59745-569-5_4. V. Georgiev, K.A. Western, J.J. McGowan (Eds.).
50. Prince A.S. The host response to anthrax lethal toxin: unexpected observations. J. Clin. Invest. 2003, 112:656-658.
51. Reynolds A., Rubin J., Clermont G., Day J., Vodovotz Y., Ermentrout B.G. A reduced mathematical model of the acute inflammatory response: I. Derivation of model and analysis of anti-inflammation. J. Theor. Biol. 2006, 242:220-236.
52. Ribot W.J., Panchal R.G., Brittingham K.C., Ruthel G., Kenny T.A., Lane D., Curry B., Hoover T.A., Friedlander A.M., Bavari S. Anthrax lethal toxin impairs innate immune functions of alveolar macrophages and facilitates Bacillus anthracis survival. Infect. Immun. 2006, 74:5029-5034.
53. Ross J.M. The pathogenesis of anthrax following the administration of spores by the respiratory route. J. Pathol. Bacteriol. 1957, 73:485-494. 10.1002/path.1700730219.
54. Ruthel G., Ribot W.J., Bavari S., Hoover T.A. Time-lapse confocal imaging of development of Bacillus anthracis in macrophages. J. Infect. Dis. 2004, 189:1313-1316.
55. Schmidt A.F., Rodrigues O.R., Matheus R.S., Kim Jdu U., Jatene F.B. Mediastinal lymph node distribution, size and number: definitions based on an anatomical study. J. Bras. Pneumol. 2007, 33:134-140.
56. Shetron-Rama L.M., Herring-Palmer A.C., Huffnagle G.B., Hanna P. Transport of Bacillus anthracis from the lungs to the draining lymph nodes is a rapid process facilitated by CD11c+ cells. Microb. Pathog. 2010, 49:38-46.
57. Stern E.J., Uhde K.B., Shadomy S.V., Messonnier N. Conference report on public health and clinical guidelines for anthrax [conference summary]. Emerg. Infect Dis. 2008, Available from.
58. Swartz M.N. Recognition and management of anthrax-an update. N. Engl. J. Med. 2001, 345:1621-1626.
59. Twenhafel N.A., Leffel E., Pitt M.L. Pathology of inhalational anthrax infection in the African green monkey. Vet. Pathol. 2007, 44:716-721.
60. Vasconcelos D., Barnewall R., Babin M., Hunt R., Estep J., Nielsen C., Carnes R., Carney J. Pathology of inhalation anthrax in cynomolgus monkeys (Macaca fascicularis). Lab. Invest. 2003, 83:1201-1209.
61. Watson L.E., Kuo S.R., Katki K., Dang T., Park S.K., Dostal D.E., Tang W.J., Leppla S.H., Frankel A.E. Anthrax toxins induce shock in rats by depressed cardiac ventricular function. PLoS One 2007, 2:e466.
62. Webb G.F., Blaser M.J. Mailborne transmission of anthrax: modeling and implications. Proc. Natl. Acad. Sci. USA 2002, 99:7027-7032.
63. Webb G.F. A silent bomb: the risk of anthrax as a weapon of mass destruction. Proc. Natl. Acad. Sci. USA 2003, 100:4355-4356.
64. Wein L.M., Craft D.L., Kaplan E.H. Emergency response to an anthrax attack. Proc. Natl. Acad. Sci. USA 2003, 100:4346-4351.
65. Wilkening D.A. Modeling the incubation period of inhalational anthrax. Med. Decis. Making 2008, 28:593-605.
66. Wright G.G., Mandell G.L. Anthrax toxin blocks priming of neutrophils by lipopolysaccharide and by muramyl dipeptide. J. Exp. Med. 1986, 164:1700-1709.